Related Experiment Video
Updated: Jun 27, 2026
07:49
Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
Published on: July 17, 2019
Gene expression deregulation by KRAS G12D and G12V in a BRAF V600E context
Massimiliano Monticone1, Emanuela Biollo, Massimo Maffei
1Centro Biotecnologie Avanzate, Genova, Italy. massimiliano.monticone@cba-biotecnologie.it
Molecular Cancer
|December 18, 2008
Summary
KRAS G12V mutations in colorectal cancer (CRC) cells reduce survival and proliferation, while G12D mutations affect chromatin and cell adhesion. KRAS G12V may indicate a more aggressive CRC phenotype.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- KRAS and BRAF mutations are crucial in solid tumor development.
- Their co-occurrence and interaction in colorectal cancer (CRC) require further investigation.
- A microsatellite stable (MSS) CRC cell line (Colo741) with BRAF mutation and wild-type KRAS (KRASWT) was used to study KRAS-BRAF interaction.
Purpose of the Study:
- To investigate the functional consequences of KRAS G12V and KRAS G12D mutations in a BRAF-mutated colorectal cancer context.
- To elucidate the interaction between KRAS and BRAF mutations in cancer progression.
- To identify potential novel pathways and biomarkers for CRC.
Main Methods:
- Gene expression profiling of KRASWT, KRAS G12V, and KRAS G12D transfected Colo741 cells.
- Reverse transcription quantitative polymerase chain reaction (RT-qPCR) for validation.
- Microarray analysis to assess gene expression changes.
Main Results:
- KRAS G12V mutation altered genes related to cell cycle and apoptosis, suggesting reduced survival and proliferation.
- KRAS G12D mutation impacted chromatin organization and cell-cell adhesion genes without affecting apoptosis.
- Distinct functional changes were observed between KRAS G12V and KRAS G12D states.
Conclusions:
- KRAS G12D mutations might be favored in a BRAF-mutated background.
- KRAS G12V mutations may lead to a more aggressive CRC phenotype by promoting angiogenesis and evading apoptosis.
- Findings support the association of KRAS G12V with worse CRC prognosis and suggest potential therapeutic targets.
More Related Videos
06:44Bioluminescence Resonance Energy Transfer (BRET)-Based Assay for Measuring Interactions of CRAF with 14-3-3 Proteins in Live Cells
Published on: March 1, 2024
10:16Employing Digital Droplet PCR to Detect BRAF V600E Mutations in Formalin-fixed Paraffin-embedded Reference Standard Cell Lines
Published on: October 8, 2015
Related Concept Videos
02:38The Ras Gene
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Ras is a superfamily...
01:24Small GTPases - Ras and Rho
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
01:07MAPK Signaling Cascades
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
01:33Cancer-Critical Genes I: Proto-oncogenes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...